Intrexon | XON - Despesas Operacionais





Despesas Operacionais Alterar Data
Agenus USD 19.81M 293.94M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Amgen USD 5.9B 773M 2025-12
Anika Therapeutics USD 29.97M 116.84M 2025-12
Arrowhead Research USD 223.22M 10.86M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Heron Therapeutics USD 40.55M 1.46M 2025-12
Incyte USD 1.12B 3.53B 2025-12
Intrexon USD 61.56M 26.1M 2024-06
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
MacroGenics USD 53.32M 13.68M 2025-12
MannKind USD 119.64M 56.29M 2025-12
Merck USD 10.16B 558M 2025-12
Novartis USD 9.8B 61M 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Veracyte USD 116M 7.24M 2025-12
Xencor USD 81.86M 13.35M 2025-12